Overview


According to FutureWise analysis the market for 3D bioprinting in 2023 is US$ 1.57 billion, and is expected to reach US$ 7.24 billion by 2031 at a CAGR of 21.00%.

A technique known as 3D bioprinting employs living cells that form structures layer by layer that mimic the behaviour and make-up of genuine tissues. Natural or artificial biomaterials combined with living cells are utilized to make the bio-inks that constitute the base for bioprinting. Thanks to technology and bio-printed components, researchers can now explore the human body's activities in vitro. Comparatively, 2D in vitro research is less biologically relevant than 3D bio-printed structures. Most of the 3D bioprinting's biological applications are in tissue engineering, bioengineering, and material science. Moreover, the technology is increasingly being used for drug research and approval. Bioprinting research focuses on clinical applications, including 3D-printed skin and bone grafts, implants, and even complete organs.

Diverse physiologically applicable deposition and assembling technologies, including direct writing, photolithography, microstamping, extrusion, laser writing, stereolithography, electro-printing, microfluidics, and inkjet deposition, are used in the developing field of 3D bioprinting. One of the main industries affected significantly by 3D bioprinting is healthcare. Due to its potential to produce tissue for synthetic tissues and organs, 3D bioprinting has become more widely recognized as a promising technique. The diagnosis and treatment of medical conditions could be drastically altered as a result of this.

FutureWise Market Research has published a report that provides an insightful analysis of 3D bioprinting market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts, the 3D bioprinting market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

  • Organovo Holdings, Inc.
  • CELLINK
  • Allevi Inc.
  • Aspect Biosystems Ltd.
  • EnvisionTEC GmbH
  • Cyfuse Biomedical K.K.
  • Poietis
  • TeVido BioDevices
  • Nano3D Biosciences, Inc.
  • ROKIT Healthcare
  • Digilab, Inc.
  • RegenHU
  • GeSiM
  • Advanced Solutions Life Sciences
  • Regenovo Biotechnology Co., Ltd.

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent developments by key players in 3D Bioprinting Market:

  • September 2022 - Systemic Bio, a new 3D bioprinting subsidiary from 3D Systems, has been introduced to quicken the research and development of new medications. The new company will benefit from recent developments made by 3D Systems in the bioprinting of vascularized human organs and tissues to reduce costs, hasten the creation of new medications, and eventually reduce or do away with animal testing.

The market for 3D bioprinting is expanding due to the pharmaceutical and healthcare sectors' ongoing technical improvements. Several government policies are also driving the industry to improve healthcare and rising R&D expenditures. For the purposes of clinical trials and medication testing, 3D bioprinters are crucial. They are anticipated to significantly lessen the need for animal testing, making them both economical and ethical. Additionally, the biological applications of 3D printing technology, or "bioprinting," broadens the fields of mechanical engineering, materials science, and human biology. These applications are also incorporated into clinical practice to give patients new, customized surgical alternatives. It is anticipated that the above-mentioned factors will increase demand for 3D bioprinting. The factors affecting the material and printing process, such as temperature, pressure, and material composition, must be precisely controlled by 3D bioprinters. Due to its complexity, the bioprinting process may be difficult to comprehend and control. Also, the experience of trained professionals is necessary to operate and maintain 3D bioprinting equipment. Furthermore, the high cost of 3D bioprinting is anticipated to restrain market expansion. The biggest issue among scientists right now is the need for organs for transplantation to extend sick people's lives or improve their survival rates. Recent developments in bio-generative engineering are looking into the possibility of regenerating organs and tissues that are compatible with the patient's body. 3D bioprinting of tissues and organs is a major achievement in tissue engineering and regenerative medicine. With the aid of 3D bioprinting, the field of transplantation has advanced, opening doors for market participants to grow their client bases and generate revenue from this target market.

By Component

  • 3D Bioprinters
    •    Microextrusion bioprinting
    •    Inkjet 3D Bioprinting
    •    Laser-assisted Bioprinting
    •    Magnetic 3D Bioprinting
    •    Other technologies
  • Bioinks
    •   Natural Bioinks
    •   Hybrid Bioinks
    •   Synthetic Bioinks

By Application

  • Research Applications
    •    Drug Research
    •    Regenerative Medicine
    •    3D Cell Culture
  •  Clinical Application
    •     Skin
    •     Bone And Cartilage
    •     Blood Vessels
    •     Other Clinical Applications

By Material

  •  Living Cells
  •  Hydrogels
  •  Extracellular Matrices
  •  Other Biomaterials

By End User

  •  Research Organization And Academic Institutes
  •  Biopharmaceuticals Companies
  •  Hospital

By Region

  •  North America
  •  Europe
  •  Asia-Pacific
  •  Latin America
  •  Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered the highest share in the market in 2022. A big portion of the market share belongs to North America due to the substantial public and private investments made in developing advanced 3D bioprinting technologies, rapid adoption, and major market participants in the area. Additionally, COVID-19's increased death rates and a shortage of organ donors are fuelling the market's expansion.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the 3D Bioprinting Market By component, application, By material, By end-user and By region.
  • To cater comprehensive insights on factors such as drivers, restraints, trends, opportunity, and additionally segmental and regional factors impacting market growth.
  • To evaluate current market trends and forecast micro-markets and the overall market projections which are represented in the format of data-sets and ppt.
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. 
  • To provide information on competitors which includes landscape mapping, technological advancements, R&D spending, news concerning strategic alliances, and new product launches

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

 

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   3D Bioprinting Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of 3D Bioprinting Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   3D Bioprinting Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   3D Bioprinting Market, By Component Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. 3D Bioprinters
         1.1. Microextrusion bioprinting
         1.2. Inkjet 3D Bioprinting
         1.3. Laser-assisted Bioprinting
         1.4. Magnetic 3D Bioprinting
         1.5. Other technologies
        2. Bioinks
         2.1. Natural Bioinks
         2.2. Hybrid Bioinks
         2.3. Synthetic Bioinks

  • 8.   3D Bioprinting Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Research Applications
         1.1. Drug Research
         1.2. Regenerative Medicine
         1.3. 3D Cell Culture
        2. Clinical Application
         2.1. Skin
         2.2. Bone and Cartilage
         2.3. Blood Vessels
         2.4. Other Clinical Applications

  • 9.   3D Bioprinting Market, By Material Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Living Cells
        2. Hydrogels
        3. Extracellular Matrices
        4. Other Biomaterials

  • 10.   3D Bioprinting Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Research Organization And Academic Institutes
        2. Biopharmaceuticals Companies
        3. Hospital

  • 11.   North America 3D Bioprinting Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 12.   Latin America 3D Bioprinting Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 13.   Europe 3D Bioprinting Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 14.   Asia Pacific 3D Bioprinting Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 15.   Middle East and Africa 3D Bioprinting Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 16.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 17.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Organovo Holdings, Inc.
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. CELLINK
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Allevi Inc.
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Aspect Biosystems Ltd.
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. EnvisionTEC GmbH
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Cyfuse Biomedical K.K.
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Poietis
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. TeVido BioDevices
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Nano3D Biosciences, Inc.
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
          10. ROKIT Healthcare
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
           11. Digilab, Inc.
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. RegenHU
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. GeSiM
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14. Advanced Solutions Life Sciences
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
        15. Regenovo Biotechnology Co., Ltd.
         15.1. Company Overview
         15.2. Product Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview

  • 18.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by
                   administrations
        5. The overall economic slowdown of the developing and developed nations

  • 19.   FutureWise SME Key Takeaway Points for Client

Related Market

Biocompatible 3D Printing Materials Market

Read More

Medical 3D Printing Plastics Market

Read More

3D Printing Medical Devices Market

Read More

Automated 3D Printing Market

Read More

Dental 3D Printing Market

Read More
Partner

Our Clients